Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
Treatment and conditionWhere it standsTrials
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine for gastroenteritisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine for rotavirus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1